NeuStim
Commercial- Indications
- Stroke, Spinal cord injury
Company intelligence / Profile preview
IPS has contributed to the successful development of FDA-cleared devices such as Neuvotion’s NeuStim™ for neurostimulation in rehabilitation. The company specializes in user-centered design and risk mitigation throughout the medical device lifecycle. It prepares clients for regulatory submissions including 510(k) and PMA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intelligent Product Solutions.